{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:54:45Z","timestamp":1784872485315,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007699","name":"University of Georgia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["75N93019C00052"],"award-info":[{"award-number":["75N93019C00052"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AI170116"],"award-info":[{"award-number":["R01AI170116"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R35GM146612"],"award-info":[{"award-number":["R35GM146612"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["75N93021C00018"],"award-info":[{"award-number":["75N93021C00018"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01AI150747"],"award-info":[{"award-number":["U01AI150747"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.vaccine.2025.126802","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:37:22Z","timestamp":1738705042000},"page":"126802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploring bias due to below-limit-of-detection values in influenza vaccine antibody modeling: A case study and instructional guide for the CIVIC study"],"prefix":"10.1016","volume":"49","author":[{"given":"Yang","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Handel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe J.","family":"Giabbanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lemacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Raynee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Skarlupka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K.","family":"Dobbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126802_bb0005","series-title":"U.S. food and drug administration","author":"Vaccine Development \u2013 101","year":"2025"},{"key":"10.1016\/j.vaccine.2025.126802_bb0010","series-title":"Study designs for evaluating different efficacy and effectiveness aspects of vaccines. American journal of epidemiology","first-page":"789","volume":"vol. 146","author":"Halloran","year":"1997"},{"key":"10.1016\/j.vaccine.2025.126802_bb0015","first-page":"225","article-title":"Global regulatory guidelines for vaccines. Nonclinical development of novel biologics, biosimilars, vaccines and specialty biologics","author":"Plitnick","year":"2013","journal-title":"Elsevier"},{"key":"10.1016\/j.vaccine.2025.126802_bb0020","author":"Recommendations announced for influenza vaccine composition for the 2024\u20132025 northern hemisphere influenza season"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126802_bb0025","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12879-019-4049-5","article-title":"HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy","volume":"19","author":"Gilbert","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126802_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126802_bb0035","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.4161\/hv.28313","article-title":"Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50\u201380 years of age","volume":"10","author":"Ross","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126802_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185666","article-title":"Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza a strains","volume":"12","author":"Nu\u00f1ez","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.126802_bb0045","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fimmu.2020.00902","article-title":"IgA responses following recurrent influenza virus vaccination","volume":"11","author":"Abreu","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.126802_bb0050","article-title":"Pre-existing immunity to influenza aids ferrets in developing stronger and broader H3 vaccine-induced antibody responses","volume":"126149","author":"Ge","year":"2024","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2025.126802_bb0080","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1002\/sim.8995","article-title":"Measuring association among censored antibody titer data","volume":"40","author":"Tran","year":"2021","journal-title":"Stat Med"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126802_bb0060","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1080\/21645515.2019.1642056","article-title":"Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses","volume":"15","author":"Carlock","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126802_bb0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132155","article-title":"Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination","volume":"5","author":"Abreu","year":"2020","journal-title":"JCI insight"},{"key":"10.1016\/j.vaccine.2025.126802_bb0070","first-page":"2288","article-title":"Dealing with the non-detected and non-quantified data. The example of the serum dioxin data in the French dioxin and incinerators study","volume":"69","author":"Zeghnoun","year":"2007","journal-title":"Organohal Comp Federal Env Agency"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126802_bb0075","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4049\/immunohorizons.1800044","article-title":"Elicitation of broadly protective antibodies following infection with influenza viruses expressing H1N1 computationally optimized broadly reactive hemagglutinin antigens","volume":"2","author":"Sautto","year":"2018","journal-title":"ImmunoHorizons"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126802_bb0085","first-page":"611","article-title":"A comparison of several methods for analyzing censored data","volume":"51","author":"Hewett","year":"2007","journal-title":"Ann Occup Hyg"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126802_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003061","article-title":"Influenza infection rates, measurement errors and the interpretation of paired serology","volume":"8","author":"Cauchemez","year":"2012","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126802_bb0095","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.vaccine.2020.12.049","article-title":"Infant immunity against viral infections is advanced by the placenta-dependent vertical transfer of maternal antibodies","volume":"40","author":"Albrecht","year":"2022","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126802_bb0100","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/infdis\/jiw380","article-title":"Seasonal influenza vaccination of children induces humoral and cell-mediated immunity beyond the current season: Cross-reactivity with past and future strains","volume":"214","author":"Reber","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126802_bb0105","series-title":"Clinical infectious diseases\u202f: An official publication of the infectious diseases society of America","first-page":"1370","article-title":"Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong","volume":"vol. 51","author":"Cowling","year":"2010"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126802_bb0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2025.126802_bb0115","first-page":"63","article-title":"Haemagglutination-inhibiting antibody to influenza virus","volume":"115","author":"de Jong","year":"2003","journal-title":"Dev Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126802_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/saep.2002.28236","article-title":"Hemagglutination inhibition assays","volume":"11","author":"Cross","year":"2002","journal-title":"Seminars Avian Exotic Pet Med"},{"key":"10.1016\/j.vaccine.2025.126802_bb0125","series-title":"AI 2008: Advances in artificial intelligence","first-page":"247","article-title":"Practical Bias variance decomposition","author":"Bouckaert","year":"2008"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126802_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1022899518027","article-title":"Variance and Bias for general loss functions","volume":"51","author":"James","year":"2003","journal-title":"Mac Learn"},{"key":"10.1016\/j.vaccine.2025.126802_bb0135","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2019"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126802_bb0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1137\/1037125","article-title":"Historical development of the Newton\u2013Raphson method","volume":"37","author":"Ypma","year":"1995","journal-title":"SIAM review SIAM"},{"key":"10.1016\/j.vaccine.2025.126802_bb0145","series-title":"maxLik: A package for maximum likelihood estimation in R. Computational statistics","first-page":"443","volume":"vol. 26","author":"Henningsen","year":"2011"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2025.126802_bb0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/01971520009349533","article-title":"Enzyme-Linked Immunosorbent Assay","volume":"21","author":"Butler","year":"2000","journal-title":"J Immunoassay Taylor & Francis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126802_bb0155","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/ije\/dyu080","article-title":"What is the difference between missing completely at random and missing at random?","volume":"43","author":"Bhaskaran","year":"2014","journal-title":"Int J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:18:49Z","timestamp":1741346329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"alternative-id":["S0264410X25000994"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126802","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring bias due to below-limit-of-detection values in influenza vaccine antibody modeling: A case study and instructional guide for the CIVIC study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126802"}}